• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将基因组和流行病学信息联系起来,推进 COVID-19 研究。

Linking genomic and epidemiologic information to advance the study of COVID-19.

机构信息

Shanghai Information Center for Life Sciences, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.

National Genomics Data Center, CAS Key Laboratory of Computational Biology, Bio-Med Big Data Center, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.

出版信息

Sci Data. 2022 Mar 30;9(1):121. doi: 10.1038/s41597-022-01237-1.

DOI:10.1038/s41597-022-01237-1
PMID:35354824
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8967863/
Abstract

The outbreak of Coronavirus Disease 2019 (COVID-19) at the end of 2019 turned into a global pandemic. To help analyze the spread and evolution of the virus, we collated and analyzed data related to the viral genome, sequence variations, and locations in temporal and spatial distribution from GISAID. Information from the Wikipedia web page and published research papers were categorized and mined to extract epidemiological data, which was then integrated with the public dataset. Genomic and epidemiological data were matched with public information, and the data quality was verified by manual curation. Finally, an online database centered on virus genomic information and epidemiological data can be freely accessible at https://www.biosino.org/kgcov/ , which is helpful to identify relevant knowledge and devising epidemic prevention and control policies in collaboration with disease control personnel.

摘要

2019 年底爆发的 2019 年冠状病毒病(COVID-19)已演变成全球大流行。为了帮助分析病毒的传播和演变,我们从 GISAID 中整理和分析了与病毒基因组、序列变异以及时空分布位置相关的数据。从 Wikipedia 网页和已发表的研究论文中获取的信息进行了分类和挖掘,以提取流行病学数据,然后将其与公共数据集整合。将基因组和流行病学数据与公共信息相匹配,并通过人工编辑验证数据质量。最后,一个以病毒基因组信息和流行病学数据为中心的在线数据库可在 https://www.biosino.org/kgcov/ 免费获取,这有助于与疾病控制人员合作识别相关知识并制定疫情防控政策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f2/8967863/442c928a4699/41597_2022_1237_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f2/8967863/9a7084c5b5f3/41597_2022_1237_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f2/8967863/531bfdfd4359/41597_2022_1237_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f2/8967863/7c5b1aa2113d/41597_2022_1237_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f2/8967863/442c928a4699/41597_2022_1237_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f2/8967863/9a7084c5b5f3/41597_2022_1237_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f2/8967863/531bfdfd4359/41597_2022_1237_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f2/8967863/7c5b1aa2113d/41597_2022_1237_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f2/8967863/442c928a4699/41597_2022_1237_Fig4_HTML.jpg

相似文献

1
Linking genomic and epidemiologic information to advance the study of COVID-19.将基因组和流行病学信息联系起来,推进 COVID-19 研究。
Sci Data. 2022 Mar 30;9(1):121. doi: 10.1038/s41597-022-01237-1.
2
SARS-CoV-2 HaploGraph: visualization of SARS-CoV-2 haplotype spread in Japan.SARS-CoV-2 单倍型图:日本 SARS-CoV-2 单倍型传播的可视化。
Genes Genet Syst. 2023 Nov 21;98(5):221-237. doi: 10.1266/ggs.23-00085. Epub 2023 Oct 14.
3
EDGE COVID-19: a web platform to generate submission-ready genomes from SARS-CoV-2 sequencing efforts.EDGE COVID-19:一个从 SARS-CoV-2 测序工作中生成可提交基因组的网络平台。
Bioinformatics. 2022 May 13;38(10):2700-2704. doi: 10.1093/bioinformatics/btac176.
4
SARS-CoV-2 historical global testing and genomic variability.SARS-CoV-2 历史全球检测和基因组变异。
BMC Infect Dis. 2022 Apr 1;22(1):322. doi: 10.1186/s12879-022-07147-2.
5
Genomic Evolution and Variation of SARS-CoV-2 in the Early Phase of COVID-19 Pandemic in Guangdong Province, China.中国广东省 COVID-19 大流行早期的 SARS-CoV-2 基因组进化和变异。
Curr Med Sci. 2021 Apr;41(2):228-235. doi: 10.1007/s11596-021-2340-3. Epub 2021 Apr 20.
6
Temporal and Location Variations, and Link Categories for the Dissemination of COVID-19-Related Information on Twitter During the SARS-CoV-2 Outbreak in Europe: Infoveillance Study.欧洲SARS-CoV-2疫情期间推特上新冠疫情相关信息传播的时间和地点变化以及链接类别:信息监测研究
J Med Internet Res. 2020 Aug 28;22(8):e19629. doi: 10.2196/19629.
7
Online Information Exchange and Anxiety Spread in the Early Stage of the Novel Coronavirus (COVID-19) Outbreak in South Korea: Structural Topic Model and Network Analysis.韩国新型冠状病毒(COVID-19)疫情早期的在线信息交流与焦虑传播:结构主题模型与网络分析
J Med Internet Res. 2020 Jun 2;22(6):e19455. doi: 10.2196/19455.
8
Assessing Public Interest Based on Wikipedia's Most Visited Medical Articles During the SARS-CoV-2 Outbreak: Search Trends Analysis.基于 SARS-CoV-2 爆发期间维基百科最受欢迎的医学文章评估公众利益:搜索趋势分析。
J Med Internet Res. 2021 Apr 12;23(4):e26331. doi: 10.2196/26331.
9
Coronavirus3D: 3D structural visualization of COVID-19 genomic divergence.冠状病毒 3D:COVID-19 基因组差异的 3D 结构可视化。
Bioinformatics. 2020 Aug 1;36(15):4360-4362. doi: 10.1093/bioinformatics/btaa550.
10
Study of the SARS-CoV-2 genomic data generation to evaluate the introduction of genomics in epidemiological surveillance and public health decision making.研究 SARS-CoV-2 基因组数据的生成,以评估基因组学在流行病学监测和公共卫生决策中的引入。
Pan Afr Med J. 2022 Jan 20;41:55. doi: 10.11604/pamj.2022.41.55.32344. eCollection 2022.

引用本文的文献

1
Early warning of emerging infectious diseases based on multimodal data.基于多模态数据的新发传染病早期预警
Biosaf Health. 2023 Jun 7;5(4):193-203. doi: 10.1016/j.bsheal.2023.05.006.
2
Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2023.2023 年中国国家生物信息中心国家基因组学数据中心数据库资源。
Nucleic Acids Res. 2023 Jan 6;51(D1):D18-D28. doi: 10.1093/nar/gkac1073.
3
Optimal control and cost-effectiveness analysis of a new COVID-19 model for Omicron strain.针对奥密克戎毒株的新型新冠病毒模型的最优控制与成本效益分析

本文引用的文献

1
Mobility, exposure, and epidemiological timelines of COVID-19 infections in China outside Hubei province.中国湖北省以外地区 COVID-19 感染的流动性、暴露和流行病学时间线。
Sci Data. 2021 Feb 5;8(1):54. doi: 10.1038/s41597-021-00844-8.
2
COVID-19 vaccines: The status and perspectives in delivery points of view.COVID-19 疫苗:交付观点中的现状和展望。
Adv Drug Deliv Rev. 2021 Mar;170:1-25. doi: 10.1016/j.addr.2020.12.011. Epub 2020 Dec 24.
3
Oxford-AstraZeneca COVID-19 vaccine efficacy.牛津大学-阿斯利康新冠疫苗的效力
Physica A. 2022 Nov 15;606:128134. doi: 10.1016/j.physa.2022.128134. Epub 2022 Aug 25.
Lancet. 2021 Jan 9;397(10269):72-74. doi: 10.1016/S0140-6736(20)32623-4. Epub 2020 Dec 8.
4
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.一项在 18-59 岁健康成年人中进行的新型冠状病毒灭活疫苗的安全性、耐受性和免疫原性的随机、双盲、安慰剂对照、1/2 期临床试验。
Lancet Infect Dis. 2021 Feb;21(2):181-192. doi: 10.1016/S1473-3099(20)30843-4. Epub 2020 Nov 17.
5
Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials.用于评估 COVID-19 疫苗试验疗效的临床终点。
Ann Intern Med. 2021 Feb;174(2):221-228. doi: 10.7326/M20-6169. Epub 2020 Oct 22.
6
Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy.用于测试疫苗效力的 SARS-CoV-2 在 BALB/c 小鼠中的适应性。
Science. 2020 Sep 25;369(6511):1603-1607. doi: 10.1126/science.abc4730. Epub 2020 Jul 30.
7
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.追踪 SARS-CoV-2 刺突蛋白的变化:D614G 增加 COVID-19 病毒感染力的证据。
Cell. 2020 Aug 20;182(4):812-827.e19. doi: 10.1016/j.cell.2020.06.043. Epub 2020 Jul 3.
8
The proximal origin of SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的近端起源。
Nat Med. 2020 Apr;26(4):450-452. doi: 10.1038/s41591-020-0820-9.
9
Epidemiological data from the COVID-19 outbreak, real-time case information.新冠疫情流行病学数据,实时病例信息。
Sci Data. 2020 Mar 24;7(1):106. doi: 10.1038/s41597-020-0448-0.
10
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19:一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.